237 related articles for article (PubMed ID: 35202387)
1. Camptothecin effectively treats obesity in mice through GDF15 induction.
Lu JF; Zhu MQ; Xie BC; Shi XC; Liu H; Zhang RX; Xia B; Wu JW
PLoS Biol; 2022 Feb; 20(2):e3001517. PubMed ID: 35202387
[TBL] [Abstract][Full Text] [Related]
2. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
[TBL] [Abstract][Full Text] [Related]
3. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.
Mullican SE; Lin-Schmidt X; Chin CN; Chavez JA; Furman JL; Armstrong AA; Beck SC; South VJ; Dinh TQ; Cash-Mason TD; Cavanaugh CR; Nelson S; Huang C; Hunter MJ; Rangwala SM
Nat Med; 2017 Oct; 23(10):1150-1157. PubMed ID: 28846097
[TBL] [Abstract][Full Text] [Related]
4. GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS.
Tsai VW; Zhang HP; Manandhar R; Schofield P; Christ D; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Brown DA; Breit SN
Int J Obes (Lond); 2019 Dec; 43(12):2370-2380. PubMed ID: 31152154
[TBL] [Abstract][Full Text] [Related]
5. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.
Yang L; Chang CC; Sun Z; Madsen D; Zhu H; Padkjær SB; Wu X; Huang T; Hultman K; Paulsen SJ; Wang J; Bugge A; Frantzen JB; Nørgaard P; Jeppesen JF; Yang Z; Secher A; Chen H; Li X; John LM; Shan B; He Z; Gao X; Su J; Hansen KT; Yang W; Jørgensen SB
Nat Med; 2017 Oct; 23(10):1158-1166. PubMed ID: 28846099
[TBL] [Abstract][Full Text] [Related]
6. GDF15 mediates the effects of metformin on body weight and energy balance.
Coll AP; Chen M; Taskar P; Rimmington D; Patel S; Tadross JA; Cimino I; Yang M; Welsh P; Virtue S; Goldspink DA; Miedzybrodzka EL; Konopka AR; Esponda RR; Huang JT; Tung YCL; Rodriguez-Cuenca S; Tomaz RA; Harding HP; Melvin A; Yeo GSH; Preiss D; Vidal-Puig A; Vallier L; Nair KS; Wareham NJ; Ron D; Gribble FM; Reimann F; Sattar N; Savage DB; Allan BB; O'Rahilly S
Nature; 2020 Feb; 578(7795):444-448. PubMed ID: 31875646
[TBL] [Abstract][Full Text] [Related]
7. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
Emmerson PJ; Wang F; Du Y; Liu Q; Pickard RT; Gonciarz MD; Coskun T; Hamang MJ; Sindelar DK; Ballman KK; Foltz LA; Muppidi A; Alsina-Fernandez J; Barnard GC; Tang JX; Liu X; Mao X; Siegel R; Sloan JH; Mitchell PJ; Zhang BB; Gimeno RE; Shan B; Wu X
Nat Med; 2017 Oct; 23(10):1215-1219. PubMed ID: 28846098
[TBL] [Abstract][Full Text] [Related]
8. Dietary medium-chain fatty acids reduce food intake via the GDF15-GFRAL axis in mice.
Kanta JM; Deisen L; Johann K; Holm S; Lundsgaard A; Lund J; Jähnert M; Schürmann A; Clemmensen C; Kiens B; Fritzen AM; Kleinert M
Mol Metab; 2023 Aug; 74():101760. PubMed ID: 37356805
[TBL] [Abstract][Full Text] [Related]
9. The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance.
Klein AB; Nicolaisen TS; Johann K; Fritzen AM; Mathiesen CV; Gil C; Pilmark NS; Karstoft K; Blond MB; Quist JS; Seeley RJ; Færch K; Lund J; Kleinert M; Clemmensen C
Cell Rep; 2022 Aug; 40(8):111258. PubMed ID: 36001956
[TBL] [Abstract][Full Text] [Related]
10. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15.
Hsu JY; Crawley S; Chen M; Ayupova DA; Lindhout DA; Higbee J; Kutach A; Joo W; Gao Z; Fu D; To C; Mondal K; Li B; Kekatpure A; Wang M; Laird T; Horner G; Chan J; McEntee M; Lopez M; Lakshminarasimhan D; White A; Wang SP; Yao J; Yie J; Matern H; Solloway M; Haldankar R; Parsons T; Tang J; Shen WD; Alice Chen Y; Tian H; Allan BB
Nature; 2017 Oct; 550(7675):255-259. PubMed ID: 28953886
[TBL] [Abstract][Full Text] [Related]
11. Body weight regulation via MT1-MMP-mediated cleavage of GFRAL.
Chow CFW; Guo X; Asthana P; Zhang S; Wong SKK; Fallah S; Che S; Gurung S; Wang Z; Lee KB; Ge X; Yuan S; Xu H; Ip JPK; Jiang Z; Zhai L; Wu J; Zhang Y; Mahato AK; Saarma M; Lin CY; Kwan HY; Huang T; Lyu A; Zhou Z; Bian ZX; Wong HLX
Nat Metab; 2022 Feb; 4(2):203-212. PubMed ID: 35177851
[TBL] [Abstract][Full Text] [Related]
12. GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway.
Breit SN; Manandhar R; Zhang HP; Lee-Ng M; Brown DA; Tsai VW
Cell Metab; 2023 Aug; 35(8):1341-1355.e3. PubMed ID: 37433299
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise.
Klein AB; Nicolaisen TS; Ørtenblad N; Gejl KD; Jensen R; Fritzen AM; Larsen EL; Karstoft K; Poulsen HE; Morville T; Sahl RE; Helge JW; Lund J; Falk S; Lyngbæk M; Ellingsgaard H; Pedersen BK; Lu W; Finan B; Jørgensen SB; Seeley RJ; Kleinert M; Kiens B; Richter EA; Clemmensen C
Nat Commun; 2021 Feb; 12(1):1041. PubMed ID: 33589633
[TBL] [Abstract][Full Text] [Related]
14. Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis.
Guo X; Asthana P; Zhai L; Cheng KW; Gurung S; Huang J; Wu J; Zhang Y; Mahato AK; Saarma M; Ustav M; Kwan HY; Lyu A; Chan KM; Xu P; Bian ZX; Wong HLX
Nat Commun; 2024 Feb; 15(1):1034. PubMed ID: 38310105
[TBL] [Abstract][Full Text] [Related]
15. Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond.
Mullican SE; Rangwala SM
Trends Endocrinol Metab; 2018 Aug; 29(8):560-570. PubMed ID: 29866502
[TBL] [Abstract][Full Text] [Related]
16. GDF15 deficiency promotes high fat diet-induced obesity in mice.
Tran T; Yang J; Gardner J; Xiong Y
PLoS One; 2018; 13(8):e0201584. PubMed ID: 30070999
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior.
Igual Gil C; Coull BM; Jonas W; Lippert RN; Klaus S; Ost M
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 36271504
[TBL] [Abstract][Full Text] [Related]
18. GDF15: A Hormone Conveying Somatic Distress to the Brain.
Lockhart SM; Saudek V; O'Rahilly S
Endocr Rev; 2020 Aug; 41(4):. PubMed ID: 32310257
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice.
Suriben R; Chen M; Higbee J; Oeffinger J; Ventura R; Li B; Mondal K; Gao Z; Ayupova D; Taskar P; Li D; Starck SR; Chen HH; McEntee M; Katewa SD; Phung V; Wang M; Kekatpure A; Lakshminarasimhan D; White A; Olland A; Haldankar R; Solloway MJ; Hsu JY; Wang Y; Tang J; Lindhout DA; Allan BB
Nat Med; 2020 Aug; 26(8):1264-1270. PubMed ID: 32661391
[TBL] [Abstract][Full Text] [Related]
20. The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
Breit SN; Brown DA; Tsai VW
Annu Rev Physiol; 2021 Feb; 83():127-151. PubMed ID: 33228454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
